1Y Close · As of Aug 26, 2026
CMG Pharmaceutical operates in the Pharmaceuticals sector.
Legal name: CMG Pharmaceutical Co., Ltd.
In fiscal year 2025, CMG Pharmaceutical (058820) reported revenue of 105.2 billion KRW, up 6.2% from 99.1 billion KRW a year earlier.
Operating profit was -3.7 billion KRW and net income was -10.1 billion KRW in the same year.
As of the Aug 26, 2026 close, the market capitalization was 81.6 billion KRW, with a P/B of 0.40.
These figures can be verified in the DART filing (receipt no. 20260319001089).
Financials
| Year | Rev | Op Inc | Net Inc |
|---|---|---|---|
| 2025 | 105.2B | -3.7B | -10.1B |
| 2024 | 99.1B | 1.0B | 2.7B |
| 2023 | 93.9B | 3.0B | 6.5B |
Recent Filings
Semi-Annual Report (2026.06)
Proxy Solicitation Reference
Meeting Notice
Checks
2 of 8 checked items currently applicable.
Market Cap & Price: Market cap is above the delisting threshold.
Administrative Designation: No administrative designation criteria met.
Audit Opinion: Audit opinion: Unqualified (clean).
Capital Increase: No capital-increase filings in the last 180 days.
Treasury Stock: No treasury stock filings.
Embezzlement & Litigation: No embezzlement or litigation filings in the last 180 days.
Major Shareholder Change: No major shareholder changes in the last 180 days.
Recent Filings
| Date | Filing |
|---|---|
| 2026-08-14 | Semi-Annual Report (2026.06) |
| 2026-08-13 | Proxy Solicitation Reference |
| 2026-08-13 | Meeting Notice |
| 2026-08-05 | Other Market Notice (Administrative Designation Concern) (Stock Price Below 1,000 KRW) |